Stockscreener 앱 받기
0.7944
11.72%
-0.1055
시간 외 거래:
.80
0.0056
+0.70%
전일 마감가:
$0.8999
열려 있는:
$0.932
하루 거래량:
800.58K
Relative Volume:
3.64
시가총액:
$411.38K
수익:
$3,200
순이익/손실:
$-42.79M
주가수익비율:
-0.000105
EPS:
-7534.7458
순현금흐름:
$-25.70M
1주 성능:
-9.73%
1개월 성능:
-79.33%
6개월 성능:
-99.88%
1년 성능:
-99.98%
1일 변동 폭
$0.7604
$1.1399
1주일 범위
$0.7561
$1.1399
52주 변동 폭
$0.7561
$5,214.72
애디텍스트 Stock (ADTX) Company Profile
명칭
Aditxt Inc
전화
909-488-0844
주소
737 N. FIFTH STREET, SUITE 200, RICHMOND
Compare ADTX vs VRTX, REGN, ARGX, ALNY, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
0.7944 | 411.38K | 3,200 | -42.79M | -25.70M | -7,534.75 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
애디텍스트 주식(ADTX)의 최신 뉴스
Setup Watch: Can Aditxt Inc grow without external funding2026 Setups & Long-Term Safe Investment Plans - baoquankhu1.vn
ADTX | Aditxt, Inc. Common Stock Executive Compensation - Quiver Quantitative
Aditxt (NASDAQ: ADTX) seeks reverse stock split and say-on-pay nod - Stock Titan
Aditxt regains compliance with Nasdaq listing standards following equity increase - Investing.com
Aditxt regains Nasdaq compliance after equity rises to $3.95M - TradingView
Aditxt (NASDAQ: ADTX) back in line with Nasdaq equity listing rules - Stock Titan
ADTX Stock Price, Quote & Chart | ADITXT INC (NASDAQ:ADTX) - ChartMill
Aditxt 10-K: Revenue $0.003M, Net loss $42.79M, EPS $(1,153.83) - TradingView
Heavy losses and Nasdaq risk at Aditxt (NASDAQ: ADTX) in 2025 10-K - Stock Titan
Aditxt, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Aditxt Expands At-The-Market Equity Offering Capacity - The Globe and Mail
Returns Recap: How does Aditxt Inc perform in inflationary periods2026 Institutional & Real-Time Volume Triggers - baoquankhu1.vn
Aditxt, Inc. Files Form 8-K for At-The-Market Offering—Key Details and Legal Opinion Included - minichart.com.sg
Aditxt increases at-the-market offering size by $36.8 million on Nasdaq - Investing.com
Aditxt increases ATM offering capacity by $36.8M, raising potential to $53.4M - TradingView
[8-K] Aditxt, Inc. Reports Material Event - Stock Titan
Trading Action: Does Aditxt Inc stock benefit from AI growth2026 Outlook & AI Forecasted Stock Moves - baoquankhu1.vn
ADTX (NASDAQ: ADTX) raises at‑the‑market capacity to $53.4M - stocktitan.net
Aditxt acquires Ignite Proteomics to expand precision oncology capabilities - MSN
Aditxt (ADTX) to vote on directors, auditor, say-on-pay, reverse split - Stock Titan
Travel Stocks: Should value investors consider Aditxt IncEarnings Growth Report & Proven Capital Preservation Methods - baoquankhu1.vn
Aug Technicals: Can Aditxt Inc grow without dilutionCPI Data & Daily Entry Point Trade Alerts - baoquankhu1.vn
Aditxt names Jeff Busch CEO of Ignite Proteomics subsidiary By Investing.com - Investing.com Canada
IMAC Surrenders Ignite Assets; Proposed $35 Million Sale to Aditxt and $36 Million Financing - TradingView
IMAC Holdings (BACK) gives up Ignite assets to satisfy defaulted notes and links $36M ADTX preferred deal - Stock Titan
Aditxt names Jeff Busch CEO of Ignite Proteomics subsidiary - Investing.com
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer - marketscreener.com
Targets Report: What are the risks of holding Aditxt Inc2026 Snapshot & Safe Swing Trade Setup Alerts - baoquankhu1.vn
ADTX Technical Analysis | Trend, Signals & Chart Patterns | ADITXT INC (NASDAQ:ADTX) - ChartMill
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
Aditxt Finalizes Ignite Proteomics Acquisition, Strengthening Oncology Focus - The Globe and Mail
Aditxt acquires precision oncology firm Ignite Proteomics By Investing.com - Investing.com South Africa
Aditxt (ADTX) Acquires Ignite Proteomics, Shares Drop 37% - GuruFocus
Aditxt acquires Ignite Proteomics in $36M preferred stock deal; shares down - MSN
Aditxt Backs Acquisition of Ignite Proteomics - themiddlemarket.com
Aditxt acquires precision oncology firm Ignite Proteomics - Investing.com Nigeria
Aditxt (ADTX) Acquires Ignite Proteomics in $36M Stock Deal - GuruFocus
Aditxt Buys Ignite Proteomics for $36M in Preferred Stock and Secures $2.88M Note Financing - TradingView
Aditxt (NASDAQ: ADTX) buys Ignite Proteomics with $36M preferred stock, adds notes - Stock Titan
Aditxt cancer move: Ignite Proteomics to guide therapy for 600,000 - Stock Titan
Aditxt, Inc. acquired Ignite Proteomics LLC from IMAC Holdings, Inc. and others for approximately $36 million. - marketscreener.com
Aditxt to implement 1-for-8 reverse stock split on March 9 - Investing.com Nigeria
ADTX SEC FilingsAditxt Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ETF Watch: Does Aditxt Inc stock benefit from AI growth2025 Analyst Calls & Weekly Top Performers Watchlists - baoquankhu1.vn
Aditxt Implements Reverse Stock Split to Maintain Nasdaq Listing - The Globe and Mail
Guidance Update: Is Aditxt Inc forming a bullish divergenceWall Street Watch & Weekly Watchlist of Top Performers - baoquankhu1.vn
Aditxt (ADTX) Implements 1-for-8 Reverse Stock Split - GuruFocus
Aditxt, Inc. (Nasdaq Adtx) announces 1-for-8 reverse stock split effective at the open of trading on March 9, 2026 - marketscreener.com
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026 - marketscreener.com
Aditxt (NASDAQ: ADTX) sets 1-for-8 reverse stock split to support Nasdaq bid - Stock Titan
Eight Aditxt shares become one as 1-for-8 Nasdaq reverse split starts March 9 - Stock Titan
애디텍스트 (ADTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.49%
1.47%
자본화:
|
볼륨(24시간):